Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 5:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 612 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Sickle Cell Disease, Thalassemia
Interventions: Transfusion, Blood, Chelation therapy; Procedure · Biological
Lead sponsor: Columbia University; Other
Eligibility: 1 Year to 65 Years
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Renal Insufficiency, Chronic, Iron-Deficiency Anemia
Interventions: Ferric maltol, Placebo; Drug · Other
Lead sponsor: Shield Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 27
States / cities: Peoria, Arizona • Phoenix, Arizona • Prescott, Arizona + 24 more

Conditions: Anemia
Interventions: Venofer; Drug
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: MRI; Other
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Menstrual Cramps, Women's Health, Fatigue
Interventions: My Happy Flo; Dietary Supplement
Lead sponsor: My Happy Flo; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Hereditary Hemorrhagic Telangiectasia
Interventions: Feraheme MRI/MRA; Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Tuberculosis, Iron Deficiency Anemia
Interventions: CHICA Diagnosis Module, CHICA Placebo; Other
Lead sponsor: Indiana University; Other
Eligibility: 3 Years to 11 Years
Enrollment: 2,239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Autosomal Dominant Hypophosphatemic Rickets
Interventions: Iron; Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 25 Months and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Chronic Kidney Disease, Iron-deficiency Anemia
Interventions: IV Iron, Ferrous Sulfate; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Nutritional Deficiency
Interventions: Pearl millet, Biofortified pearl millet; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Months to 36 Months
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Chronic Kidney Disease Requiring Chronic Dialysis
Interventions: PA21 (2.5 g tablet containing 500 mg iron), Sevelamer carbonate, PA21-1 (1.25 g tablet containing 250 mg iron); Drug
Lead sponsor: Vifor Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 1,059 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Bleeding Disorders, Iron, Platelet, Bleeding
Interventions: IV Iron (standard of care); Drug
Lead sponsor: Nicoletta C Machin; Other
Eligibility: 15 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy Volunteers
Interventions: AKB-6548, Ferrous Sulfate; Drug
Lead sponsor: Akebia Therapeutics; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: Anemia, Sickle Cell, Transfusion Hemosiderosis
Interventions: deferasirox; Drug
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 14 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Iron, Diabetes, Nonalcoholic Fatty Liver
Interventions: Blood Donation, Sham Blood Donation; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years to 75 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Winston-Salem, North Carolina

Conditions: Iron-deficiency, Iron Deficiency Anemia
Interventions: Meal; Other
Lead sponsor: Florida State University; Other
Eligibility: Not listed
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Anemic, Critically Ill Patients
Interventions: Ferrous Sulfate, Placebo Oral Tablet; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Iron Deficiency, Iron Deficiency Anemia (IDA), Vitamin D Deficiency, Vitamin D Insufficiency, Low Energy Availability, Bone Density
Interventions: Iron and Vitamin D Deficiencies Correction; Dietary Supplement
Lead sponsor: Morehouse School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Iron-deficiency
Interventions: Synbiotic Supplement, Placebo; Dietary Supplement
Lead sponsor: Marywood University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Anemia
Interventions: Not listed
Lead sponsor: Cornell University; Other
Eligibility: 1 Day to 18 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Anemia, Mortality
Interventions: Early anemia diagnosis and treatment, No change from normal routine; Other
Lead sponsor: Fresenius Medical Care North America; Industry
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 42
States / cities: Denver, Colorado • Jacksonville, Florida • Chicago, Illinois + 33 more

Conditions: Iron
Interventions: Ferrous sulfate, IHAT, Aspiron, Placebo; Dietary Supplement · Other
Lead sponsor: Tufts University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Iron Absorption
Interventions: Exercise test; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 45 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Anemia of End Stage Renal Disease
Interventions: Specimen collection; Other
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 3
States / cities: Louisville, Kentucky • Springfield, Massachusetts • Durham, North Carolina

Search by objective public record fields.

Effects of Transfusion of Older Stored Red Cells

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months

A Study to Assess the Effect of My Happy Flo on Alleviating Period Symptoms and Heavy Flows.

MRA With Feraheme in HHT

Universal Screening for Tuberculosis and Anemia With the CHICA System

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

Zinc and Iron Bioavailability From Biofortified Pearl Millet

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders

Effects of Ferrous Sulfate on the Pharmacokinetics of AKB-6548

Clinical Importance of Treating Iron Overload in Sickle Cell Disease

Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Iron Absorption and Exercise

Efficacy of Enteral Iron Supplementation in Critical Illness

Collegiate Athlete Study

How Does a Synbiotic Supplement Affect Iron Status During Iron Repletion in Iron Depleted Female Athletes?

Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

The Effects of Acute Erythropoietin on Hepcidin and Dietary Iron Absorption Following Military-relevant Exercise in Energy Deficit: Pilot Study

Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease